Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

MCo-PG1 shows good efficacy in Pseudomonas aeruginosa-driven sepsis model

May 15, 2020

Researchers identify AMRC-835 for MBL-positive Gram-negative bacterial infections

May 15, 2020

Kaleido initiates developmental program of KB-109 in mild to moderate COVID-19

May 15, 2020

Abivax receives clearance to initiate phase IIb/III study of ABX-464 COVID-19 patients

May 15, 2020

Immunic receives approval to begin phase II study of IMU-838 for COVID-19

May 14, 2020

New compounds target SARS-CoV-2 main protease Mpro

May 13, 2020

Veru cleared by FDA to begin phase II study of VERU-111 for COVID-19

May 13, 2020

Blade Therapeutics begins phase II study of BLD-2660 in hospitalized patients with COVID-19

May 13, 2020

New anthelmintic compounds patented by Bayer

May 13, 2020

ALS-8112, a parent nucleoside of lumicitabine, inhibits Nipah virus in vitro

May 13, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....